Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Metformin
100%
Anticancer Effect
100%
Tamoxifen-resistant Breast Cancer
100%
Breast Cancer Cell Lines
100%
Estrogen Receptor-positive
100%
MCF-7
75%
Estrogen Receptor
50%
Tamoxifen Resistance
50%
MRNA Level
25%
Protein Level
25%
Breast Cancer Cells
25%
Anticancer Activity
25%
Estrogen Receptor-positive Breast Cancer
25%
Type 2 Diabetes Mellitus (T2DM)
12%
Cell Proliferation Inhibition
12%
Signaling Pathway
12%
Therapeutic Agents
12%
Cyclin D1 (CCND1)
12%
Progesterone Receptor
12%
Estrogen
12%
C-Myc
12%
Transcriptional Activity
12%
Luciferase Activity
12%
Regulated Genes
12%
Antiestrogen
12%
Estrogen Receptor Status
12%
Expression Activity
12%
Novel Anticancer Agent
12%
Estrogen Response Element
12%
Cancer Cell Resistance
12%
Biguanide Derivatives
12%
Medicine and Dentistry
Tamoxifen
100%
Glycon
100%
Estrogen Receptor
100%
Breast Cancer Cell Line
100%
MCF-7
75%
Breast Cancer
37%
Cancer Cell
25%
Estrogen Receptor Positive Breast Cancer
25%
Messenger RNA
25%
Cell Proliferation
12%
Therapeutic Agent
12%
Signal Transduction
12%
Receptor Expression
12%
Maturity Onset Diabetes of the Young
12%
Anticarcinogen
12%
Progesterone Receptor
12%
Antineoplastic Activity
12%
Cyclin D1
12%
Luciferase
12%
Oncogene C Myc
12%
Biguanide Derivative
12%
Estrogen Responsive Element
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Estrogen Receptor
100%
Tamoxifen
100%
Metformin
100%
Estrogen Receptor Positive Breast Cancer
25%
Messenger RNA
25%
Anticarcinogen
12%
Luciferase
12%
Cyclin D1
12%
Progesterone Receptor
12%
Biguanide Derivative
12%
Non Insulin Dependent Diabetes Mellitus
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Anticancer
100%
Estrogen Receptor
100%
Messenger RNA
22%
Cell Proliferation
11%
Signal Transduction
11%
Progesterone Receptor
11%
Luciferase
11%
Oncogene C Myc
11%
Cyclin D1
11%
Antineoplastic Activity
11%
Estrogen Responsive Element
11%